Tanuja Chitnis is a Neurology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 684 publications with 34,762 citations (h-index 86). By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit Street Yaw 6
Pediatric Neurology
Boston, MA 02114
Telephone
617-726-6093Registry record last updated 8 Jul 2007.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20257 payments$19,456openpaymentsdata.cms.gov ↗
- SANOFI US SERVICES INC.Program year20255 payments$13,825openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year20259 payments$13,014openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
43.7%Other immunosuppressants13.6%Dimethyl Fumarate72%Tecfidera28%Part D<11 patientsInterferon beta9.5%Plegridy Pen60%Betaseron40%Part D<11 patients+ 3 more classes in this area
Nervous system
38.6%Gabapentinoids9.5%Gabapentin100%Part D<11 patientsSympathomimetic-like Agent7%Modafinil100%Part D<11 patients+ 5 more classes in this area
Musculoskeletal
13.9%gamma-Aminobutyric Acid-ergic Agonist13.9%Baclofen100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2005–2023 per NIH RePORTER. The latest:
- Spatial mapping of MS genetics on affected brain tissue
Brigham and Women'S Hospital
FY2023$219,867R21NS123826 - Spatial mapping of MS genetics on affected brain tissue
Brigham and Women'S Hospital
FY2022$283,230R21NS123826 - Mechanisms of Neurodegeneration & Neuroprotection in EAE
Brigham and Women'S Hospital
FY2009$175,176K08NS047669
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”